Section: Monmouth Medical Center News

Monmouth Medical Center Lung Cancer Screening Program Joins Prestigious International Organization

09/17/2013

Long Branch, N.J. – Monmouth Medical Center, a Barnabas Health facility, recently announced it has joined the International Early Lung Cancer Action Program (I-ELCAP), an international, collaborative group consisting of experts on lung cancer and related issues from around the world.

Comprised of dozens of institutions throughout the world, I-ELCAP’s mission is to achieve early diagnosis, treatment and ultimate cure of lung cancer through the rapid dissemination and advancement of research among a diversified, collaborative network. Monmouth Medical Center is among six I-ELCAP sites in New Jersey, including Barnabas Health sister hospitals Newark Beth Israel Medical Center and Saint Barnabas Medical Center.

"As a comprehensive cancer program, modern low-dose CT screening enables us to detect and ultimately treat lung cancer in its earliest most curable stages. As an I-ELCAP center, we have committed to ensuring high-quality, early detection lung cancer screening and advanced treatments are made available to those in our community,” said Loki Skylizard, M.D., FCCP, Chief of Thoracic Surgery, Director of Minimally Invasive and Robotic Thoracic Surgery and Director of the Thoracic Surgical Oncology Program at Monmouth Medical Center.

The only hospital to serve as a screening site in Monmouth and Ocean counties, Monmouth Medical Center’s Lung Cancer Research Screening and Lung Nodule program utilizes low-dose CT scans to screen candidates and detect lung cancers before they can be seen on x-rays. The U.S. Preventive Services Task Force recommends annual low-dose CT screenings for individuals between ages 55 and 79 years old and are current or former smokers. When lung cancer is diagnosed at an early stage (Stage IA ), and treated, the survival rate increases to more than 70 percent. The best way of increasing the chances of curing lung cancer is to find it early.

For more information about Monmouth Medical Center’s Lung Cancer Screening Research Program or to find out if you are a candidate, visit www.mmccancer.com or call 732-923-7966.

Loki Skylizard, MD FCCP
Loki Skylizard, M.D., FCCP, Chief of Thoracic Surgery, Director of Minimally Invasive and Robotic Thoracic Surgery and Director of the Thoracic Surgical Oncology Program at Monmouth Medical Center

About Monmouth Medical Center
Located in Long Branch, N.J., Monmouth Medical Center, a Barnabas Health facility, along with The Children’s Hospital at Monmouth Medical Center, is one of New Jersey's largest academic medical centers and has been a teaching affiliate of Philadelphia’s Drexel University College of Medicine for more than 40 years. From its earliest days, Monmouth Medical Center has been a leader in surgical advancement and has introduced many technological firsts to the region, including robotic surgery and other minimally invasive techniques. The hospital is routinely recognized by HealthGrades, the nation’s largest premier independent health care quality company, for excellence in both emergency medicine and maternity care. U.S. News & World Report has recognized Monmouth as a regional leader in cancer, geriatrics, gynecology, neurology and neurosurgery. For more information on Monmouth Medical Center, visit www.barnabashealth.org.

Date: September 17, 2013

Contact: Elizabeth Brennan
732-923-5005
ebrennan@barnabashealth.org

Categories: Cancer,Lung,Press Releases